<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting—IL AD

Giuseppe Lauletta(University of Naples Federico II), Maddalena Napolitano(University of Molise), Agostina Legori(Istituto Ortopedico Galeazzi), Massimo Gola(University of Florence), Francesco Loconsole(University of Bari Aldo Moro), Luigi Gargiulo(Humanitas University), Giampiero Girolomoni(University of Verona), Mariateresa Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Carlotta Gurioli(University of Bologna), Alberto Maria Bertoldi, Piergiorgio Malagoli(IRCCS Policlinico San Donato), Anna Campanati(Marche Polytechnic University), Pina Brianti(Vita-Salute San Raffaele University), Luca Stingeni(University of Perugia), Teresa Grieco(Sapienza University of Rome), Francesca Caroppo(University of Padua), Mario Bruno Guanti(University of Modena and Reggio Emilia), Luca Potestio(University of Naples Federico II), Angelo Massimiliano D’Erme(University of Florence), Michela Ortoncelli, Elena Pezzolo(Ospedale San Bortolo), Cataldo Patruno(Magna Graecia University), Luisa Angileri(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Claudio Sciarrone(Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte), Francesca Satolli(University of Parma), Silvia Mariel Ferrucci(University of Milan), Alessandra Narcisi(IRCCS Humanitas Research Hospital), Nicola Milanesi(Ospedale del Ceppo), Francesca Barei(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Katharina Hansel(University of Ferrara), Maria Letizia Musumeci(University of Catania), Elisabetta Magnaterra(University of Florence), Ersilia Tolino(Sapienza University of Rome), Simone Ribero
Dermatitis
June 5, 2025
Cited by 4


Related Papers